Skip to main content
. 2009 Nov 24;102(1):144–150. doi: 10.1038/sj.bjc.6605449

Table 1. Antibodies used.

Antibody Clone Titre Company
Anti-CDX2 CDX-88 1 : 50 Biogenex, San Ramon, CA, USA
Anti-CK7 OVT-TL 12/30 1 : 100 Dako, Carpinteria, CA, USA
Anti-CK20 KS20.8 1 : 4000 Dako, Carpinteria, CA, USA
Anti-EGFR 31G7 1 : 50 Invitrogen, Inc., Carlsbad, CA, USA
Anti-HER2 neu Ab8 1 : 300 Labvision, Inc., Fremont, CA, USA
Anti-MLH-1 G168-15 1 : 25 BD Biosciences, San Jose, CA, USA
Anti-MSH-2 FE11 1 : 100 Calbiochem, Inc., Gibbstown, NJ, USA
Anti-MSH-6 44 1 : 300 BD Biosciences, San Jose, CA, USA
Anti-PMS2 A16-4 1 : 125 BD Biosciences, San Jose, CA, USA
Anti-PTEN 28H6 1 : 100 Novacastra, Bannockburn, IL, USA
Anti-VEGF-A VEGF A20 1 : 10 Santa Cruz Biotechnology, Santa Cruz, CA, USA

Abbreviations: CDX2=caudal type homeobox transcription factor 2; EGFR=epidermal growth factor receptor; MLH-1=MutL homologue 1; MSH-2=MutS homologue 2; PMS2=post meiotic segregation increased 2; PTEN=phosphatase and tensin homologue mutated on chromosome 10; VEGF-A=vascular endothelial growth factor A.